Treatment Response and Tolerability of Pegylated Interferon-α Plus Ribavirin Combination Therapy in elderly Patients (≥ 65 years) With Chronic Hepatitis C in Korea

BACKGROUND: The prevalence of hepatitis C virus (HCV) infections in elderly patients has been increasing in a number of countries. A few reports concerning pegylated interferon-α (PEG-IFN-α)-based combination treatment in elderly chronic hepatitis C (CHC) patients have been published, with slightly...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyeong Il, Kim, In Hee, Jeon, Byung Jun, Lee, Seok, Kim, Seong Hun, Kim, Sang Wook, Lee, Seung Ok, Lee, Soo Teik, Kim, Dae Ghon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437453/
https://www.ncbi.nlm.nih.gov/pubmed/23008722
http://dx.doi.org/10.5812/hepatmon.6170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437453/
https://www.ncbi.nlm.nih.gov/pubmed/23008722
http://dx.doi.org/10.5812/hepatmon.6170

Ejemplares similares